HbA1c during early pregnancy reflects beta-cell dysfunction in women developing GDM

INTRODUCTION: It is of current interest to assess eligibility of hemoglobin A1c (HbA1c) as a screening tool for earlier identification of women with risk for more severe hyperglycemia in pregnancy but data regarding accuracy are controversial. We aimed to evaluate if HbA1c mirrors pathophysiological...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozkurt, Latife, Göbl, Christian S, Leitner, Karoline, Pacini, Giovanni, Kautzky-Willer, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607595/
https://www.ncbi.nlm.nih.gov/pubmed/33132213
http://dx.doi.org/10.1136/bmjdrc-2020-001751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607595/
https://www.ncbi.nlm.nih.gov/pubmed/33132213
http://dx.doi.org/10.1136/bmjdrc-2020-001751

Ejemplares similares